| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
200,635.90 | 270,756.37 | 307,806.69 | 390,819.13 | 404,365.59 |
| Cost of Revenue
|
-131,162.84 | -160,860.85 | -180,482.12 | -209,672.13 | -224,711.66 |
|
Gross Profit
|
69,473.06 | 109,895.52 | 127,324.57 | 181,147 | 179,653.93 |
| Selling, General and Administrative Expenses
|
-40,975.01 | -42,026.51 | -48,046.11 | -47,870.40 | -92,377.97 |
|
Research and Development Expenses
|
-20,499.36 | -23,248.01 | -23,361.55 | -27,946.29 | -24,369.97 |
| Depreciation, Amortization and Depletion
|
-5,508.88 | -5,702.79 | -6,250.19 | -5,254.02 | -9,890.26 |
|
Taxes Other Than Income Taxes
|
-2,103.10 | -2,859.94 | -2,850.17 | -2,883.56 | -2,914.04 |
| Other Income/Expense, Operating
|
326.44 | 900.02 | 663.88 | 1,696.63 | 2,183.27 |
|
Operating Income/Expenses
|
-68,953.82 | -72,937.24 | -79,844.15 | -82,257.64 | -76,234.86 |
|
Total Operating Profit/Loss
|
519.24 | 36,958.28 | 47,480.42 | 98,889.36 | 103,419.07 |
| Total Net Finance Income/Expense
|
-2,180.96 | -746.74 | 1,631.04 | 5,082.40 | 9,846.71 |
| Net Investment Income
|
7,149.90 | 8,467.14 | 13,915.99 | 3,930.42 | 35.11 |
| Irregular Income/Expenses
|
-25,082.28 | -20,473.82 | -30,333.60 | -24,203.20 | -16,181.31 |
|
Other Income/Expense, Non-Operating
|
-52.93 | -398.86 | -118.05 | 6,569.86 | 303.07 |
|
Non-Operating Income/Expenses, Total
|
-20,166.27 | -13,152.28 | -14,904.61 | -8,620.54 | -10,919.77 |
|
Pretax Income
|
-19,647.03 | 23,806 | 32,575.81 | 90,268.82 | 92,499.30 |
|
Provision for Income Tax
|
5,058.62 | -1,983.89 | -3,747.53 | -11,568.64 | -12,232.66 |
|
Net Income from Continuing Operations
|
-14,588.41 | 21,822.11 | 28,828.28 | 78,700.18 | 80,266.63 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-14,588.41 | 21,822.11 | 28,828.28 | 78,700.18 | 80,266.63 |
|
Non-Controlling/Minority Interests
|
36.15 | 310.66 | 230.50 | -646.89 | -720.06 |
|
Net Income after Non-Controlling/Minority Interests
|
-14,552.25 | 22,132.77 | 29,058.78 | 78,053.29 | 79,546.57 |
|
Net Income Available to Common Stockholders
|
-14,552.25 | 22,132.77 | 29,058.78 | 78,053.29 | 79,546.57 |
| Basic EPS
|
-0.14 | 0.19 | 0.25 | 0.80 | 0.93 |
| Diluted EPS
|
-0.14 | 0.19 | 0.25 | 0.80 | 0.93 |
|
Basic Weighted Average Shares Outstanding
|
118,826.83 | 116,488.25 | 116,235.13 | 97,708.17 | 85,587.32 |
|
Diluted Weighted Average Shares Outstanding
|
118,826.83 | 116,488.25 | 116,235.13 | 97,708.17 | 85,587.32 |
|
Reported Normalized Basic EPS
|
-0.04 | 0.13 | 0.18 | 0.72 | -- |
|
Reported Normalized Diluted EPS
|
-0.04 | 0.13 | 0.18 | 0.72 | -- |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-17,526.02 | 24,460.12 | 30,816.87 | 85,047.30 | 82,548.02 |
12/31/2022 - 7/19/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade